EarningsQ4 2023 Earnings Report

Protagonist Therapeutics (PGF) Q4 2023 Earnings Report

1 Followers

DE:PGF Q4 2023 EPS Results

Actual EPS€0.39

Consensus EPS€0.05

Beat/MissBeat by +€0.34

One Year Ago EPS-€0.62

Actual Revenue€53.55M

Expected Revenue€53.55M

Beat/MissMet expectations

YoY Revenue Growth―

QuarterQ4 2023

Date02/27/2024

TimeAfter Close

Conference CallTuesday, February 27, 2024

DE:PGF Upcoming Earnings

Protagonist Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	2.17 / -	-0.553	―
Aug 05, 2026	2026 (Q2)	1.98 / 2.04	-0.491	516.36% (+2.53)
May 05, 2026	2026 (Q1)	-0.42 / 0.04	-0.17	126.32% (+0.21)
Feb 25, 2026	2025 (Q4)	-0.51 / -0.62	1.767	-134.85% (-2.38)
Nov 06, 2025	2025 (Q3)	-0.56 / -0.55	-0.482	-14.81% (-0.07)
Aug 06, 2025	2025 (Q2)	-0.52 / -0.49	-0.446	-10.00% (-0.04)
Apr 30, 2025	2025 (Q1)	-0.17 / -0.17	2.91	-105.67% (-3.07)
Feb 21, 2025	2024 (Q4)	1.03 / 1.77	0.393	350.00% (+1.37)
Nov 07, 2024	2024 (Q3)	-0.52 / -0.48	-0.518	6.90% (+0.04)
Aug 06, 2024	2024 (Q2)	-0.53 / -0.45	-0.607	26.47% (+0.16)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed